Benjamin Kornitzer - Dec 15, 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Role
Chief Med. & Quality Officer
Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Dec 15, 2022
Transactions value $
$28,229
Form type
4/A - Amendment
Date filed
1/9/2023, 04:13 PM
Date Of Original Report
Dec 19, 2022
Previous filing
Dec 7, 2022
Next filing
Jan 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Options Exercise $20.3K +4.51K +43.27% $4.49* 14.9K Dec 16, 2022 Direct F1
transaction AGL Common Stock Options Exercise $7.97K +887 +5.94% $8.99 15.8K Dec 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGL Options (Rights to Buy) Options Exercise $0 -4.51K -1.61% $0.00 275K Dec 16, 2022 Common Stock 4.51K $4.49 Direct F2
transaction AGL Options (Rights to Buy) Options Exercise $0 -887 -0.35% $0.00 249K Dec 16, 2022 Common Stock 887 $8.99 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units.
F2 These options were granted on January 31, 2020 and vest in four equal installments on January 31 of each of 2021, 2022, 2023, and 2024.
F3 These options were granted on January 31, 2020 and vested on September 14, 2021.

Remarks:

This Form 4 Amendment corrects the tranche of 887 vested options exercised by the Reporting Filer as reported on the Form 4 filed on December 19, 2022.